RESEARCH ARTICLE

Antiviral Treatment to Prevent Transmission of Hepatitis C in People Who Inject Drugs

Open Medicine Journal 29 July 2016 RESEARCH ARTICLE DOI: 10.2174/1874220301603010130

Abstract

The hepatitis C virus (HCV) is common among people who inject drugs (PWID) and causes significant morbidity and mortality. Opiate replacement therapy and needle exchange programs have effectively prevented the transmission of the Human immunodeficiency virus (HIV) but have been less effective for HCV. Other HCV prevention strategies are needed. Antiviral therapy with all oral direct acting antivirals is currently available and appears to be highly effective even in PWID and offers a possible strategy to further prevention efforts. This paper will review current evidence for treatment as prevention for HCV in PWID.

Keywords: Access to care, Direct acting antivirals, Injection drug use, Liver Disease, Prevention, Substance use disorder.
Fulltext HTML PDF ePub
1800
1801
1802
1803
1804